CN: 32-1845/R
ISSN: 2095-6975
Cite this paper:
0
ZHAO Guang, ZHUO Yu-Zhen, CUI Li-Hua, LI Cai-Xia, CHEN Sha-Yan, LI Dan, LIU Jun-Hong, LI Di-Hua, CUI Nai-Qiang, ZHANG Shu-Kun. Modified Da-chai-hu Decoction regulates the expression of occludin and NF-κB to alleviate organ injury in severe acute pancreatitis rats[J]. Chinese Journal of Natural Medicines, 2019, 17(5): 355-362

Modified Da-chai-hu Decoction regulates the expression of occludin and NF-κB to alleviate organ injury in severe acute pancreatitis rats

ZHAO Guang1,2, ZHUO Yu-Zhen2,3, CUI Li-Hua2,3, LI Cai-Xia2,3, CHEN Sha-Yan2,4, LI Dan1,2, LIU Jun-Hong3, LI Di-Hua3, CUI Nai-Qiang1,2, ZHANG Shu-Kun2,3
1 Hepatobiliary and Pancreatic Surgery, Tianjin Nankai Hospital, Tianjin Hospital of Integrated Traditional Chinese and Western medicine, Tianjin 300100, China;
2 Nankai Clinical College, Tianjin Medical University, Tianjin 300107, China;
3 Institute of Integrated Traditional Chinese and Western medicine, Tianjin Nankai Hospital, Tianjin Hospital of Integrated Tradi-tional Chinese and Western medicine, Tianjin 300100, China;
4 Department of Clinical Laboratory, Tianjin Nankai Hospital, Tianjin Hospital of Integrated Traditional Chinese and Western medicine, Tianjin 300100, China
Abstract:
Modified Da-chai-hu Decoction (MDD), a traditional Chinese medicinal formulation, which was empirically generated from Da-chai-hu decoction, has been utilized to treat severe acute pancreatitis (SAP) for decades. The aim of the present study was to explore its potential organprotective mechanism in SAP. In the present study, rat SAP model was induced by retrograde injection of 3.5% sodium taurocholate into the biliopancreatic duct, MDD (23.35 g/kg body weight, twelve times the clinical dose) were orally given at 2 h before and 10 h after injection. At 12 h after model induction, blood was taken from vena cava for analysis of amylase, diamine oxidase (DAO), pulmonary surfactant protein-A (SP-A), and C-reactive protein (CRP). Histopathological change of pancre-as, ileum and lung was assayed by H&E staining, myeloperoxidase (MPO) activity were determinated using colorimetric assay, and the expressions of occludin and nuclear factor-κB (NF-κB) were detected by real-time RT-PCR and western blot, respectively. In addition, the tissue concentrations of tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and monocyte chemoattractant protein-1 (MCP-1) were measured by enzyme-linked immunosorbent assay (ELISA). The results showed that in SAP rats, MDD significantly alleviated histopathological damage, depressed the MPO activity and the concentrations of TNF-α, IL-1β, and MCP-1 of pancreas, ileum and lung, and reduced the serum levels of amylase[(3283.4 ±585.5) U·L-1 vs (5626.4 ±795.1) U·L-1], DAO[(1100.1 ±334.3) U·L-1 vs (1666.4 ±525.3) U·L-1] and CRP[(7.6 ±1.2) μg·mL-1 vs (17.8 ±3.8) μg·mL-1]. However, the serum SP-A concentration[(106.1 ±16.6) pg·mL-1 vs (90.1 ±14.9) pg·mL-1] was elevated when treated SAP rats with MDD. Furthermore, MDD increased the occludin expression and reduced the NF-κB expression in pancreas, ileum and lung of SAP rats. Our findings suggested that MDD administration was an effective therapeutic approach for SAP treatment. It could up-regulate occludin expression to protect intercellular tight junction and down-regulate NF-κB expression to inhibit inflammatory reaction of pancreas, ileum and lung.
Key words:    Severe acute pancreatitis    Modified Da-chai-hu Decoction    Occludin    Nuclear factor-κB    Ileum    Lung   
Received: 2019-03-11   Revised:
Tools
PDF (2994 KB) Free
Print this page
Email this article to others
Authors
Articles by ZHAO Guang
Articles by ZHUO Yu-Zhen
Articles by CUI Li-Hua
Articles by LI Cai-Xia
Articles by CHEN Sha-Yan
Articles by LI Dan
Articles by LIU Jun-Hong
Articles by LI Di-Hua
Articles by CUI Nai-Qiang
Articles by ZHANG Shu-Kun
References:
[1] Malmstrøm ML, Hansen MB, Andersen AM, et al. Cytokines and organ failure in acute pancreatitis:inflammatory response in acute pancreatitis[J]. Pancreas, 2012, 41(2):271-277.
[2] Kwong WT, Ondrejková A, Vege SS. Predictors and outcomes of moderately severe acute pancreatitis-Evidence to reclassify[J]. Pancreatology, 2016, 16(6):940-945.
[3] Yang CJ, Chen J, Phillips AR, et al. Predictors of severe and critical acute pancreatitis:a systematic review[J]. Dig Liver Dis, 2014, 46(5):446-451.
[4] Liu H, Li W, Wang X, et al. Early gut mucosal dysfunction in patients with acute pancreatitis[J]. Pancreas, 2008, 36(2):192-196.
[5] Dave A, Craig JE, Sharma S. The status of intercellular junctions in established lens epithelial cell lines[J]. Mol Vis, 2012, 18:2937-2946.
[6] Schmitt M, Klonowski-Stumpe H, Eckert M, et al. Disruption of paracellular sealing is an early event in acute caerulein- pancreatitis[J]. Pancreas, 2012, 28(2):181-190.
[7] Naydenov NG, Baranwal S, Khan S, et al. Novel mechanism of cytokine-induced disruption of epithelial barriers:Janus kinase and protein kinase D-dependent downregulation of junction protein expression[J]. Tissue Barriers, 2013, 1:e25231.
[8] Xia XM, Li BK, Xing SM, et al. Emodin promoted pancreatic claudin-5 and occludin expression in experimental acute pancreatitis rats[J]. World J Gastroenterol, 2012, 18(17):2132-2139.
[9] You K, Xu X, Fu J, et al. Hyperoxia disrupts pulmonary epithelial barrier in newborn rats via the deterioration of occludin and ZO-1[J]. Respir Res, 2012, 13:36
[10] Huang H, Liu Y, Daniluk J, et al. Activation of nuclear factor-κB in acinar cells increases the severity of pancreatitis in mice[J]. Gastroenterology, 2013, 144(1):202-210.
[11] Oiva J, Mustonen H, Kylänpää ML, et al. Acute pancreatitis with organ dysfunction associates with abnormal blood lymphocyte signaling:controlled laboratory study[J]. Crit Care, 2010, 14:R207.
[12] Kim MJ, Bae GS, Jo IJ, et al. Loganin protects against pancreatitis by inhibiting NF-κB activation[J]. Eur J Pharmacol, 2015, 765:541-550.
[13] Fan YT, Yin GJ, Xiao WQ, et al. Rosmarinic acid attenuates sodium taurocholate-induced acute pancreatitis in rats by inhibiting nuclear factor-κB activation[J]. Am J Chin Med, 2015, 43(6):1117-1135.
[14] Tianjin Nankai Hospital. Treatment of acute abdomen with integrated traditional Chinese and Western Medicine guided by Mao Zedong's Philosophical Thought[J]. New J Med, 1972, 2:17-21.
[15] Zhang JW, Zhang GX, Chen HL, et al. Therapeutic effect of Qingyi decoction in severe acute pancreatitis-induced intestinal barrier injury[J]. World J Gastroenterol, 2015, 21(12):3537- 3546.
[16] Zhang SK, Cui NQ, Zhao G, et al. Effect of Qing Yi granules on the expression of Claudin-1 of ileum in rats with severe acute pancreatitis[J]. Chin J Gen Surg, 2010, 19(16):250-252.
[17] Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy[J]. Ann Surg, 1992, 215(1):44-56.
[18] Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal[J]. Arch Surg, 1970, 101(4):478- 483.
[19] Elder AS, Saccone GT, Bersten AD, et al. Evaluation of lung injury and respiratory mechanics in a rat model of acute pancreatitis complicated with endotoxin[J]. Pancreatology, 2012, 12(3):240-247.
[20] Ting CT, Kuo CJ, Hu HY, et al. Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan:a cross-sectional analysis of the National Health Insurance Research Database[J]. BMC Complement Altern Med, 2017, 17:118.
[21] Xie W, Zhao Y, Du L. Emerging approaches of traditional Chinese medicine formulas for the treatment of hyperlipidemia[J]. J Ethnopharmacol, 2012, 140(2):3453-67.
[22] Shrimali D, Shanmugam MK, Kumar AP, et al. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer[J]. Cancer Lett, 2013, 341(2):139-149.
[23] Ma F, Hu L, Yu M, et al. Emodin decreases hepatic hypoxia-inducible factor-1 by inhibiting its biosynthesis[J]. Am J Chin Med, 2016, 44(5):997-1008.
[24] Hu HL, Zhang Q, Kong B, et al. Expression of pancreatic regenerating gene in lung and intestinal tissue correlates with the severity of disease in rats with acute necrotizing pancreatitis[J]. Mol Med Rep, 2013, 7(2):503-508.
[25] Mittal A, Hickey AJ, Chai CC, et al. Early organ-specific mitochondrial dysfunction of jejunum and lung found in rats with experimental acute pancreatitis[J]. HPB (Oxford), 2011, 13(5):332-341.
[26] Luan ZG, Zhang H, Ma XC, et al. Role of high-mobility group box 1 protein in the pathogenesis of intestinal barrier injury in rats with severe acute pancreatitis[J]. Pancreas, 2010, 39(2):216-223.
[27] Kobayashi M, Takeuchi T, Ohtsuki Y. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis[J]. Pathol Int, 2008, 58(3):203-207.
[28] Ishibashi T, Zhao H, Kawabe K, et al. Blocking of monocyte chemoattractant protein-1(MCP-1) activity attenuates the severity of acute pancreatitis in rats[J]. J Gastroenterol, 2008, 43(1):79-85.
[29] Rau B, Baumgart K, Krüger CM, et al. CC-chemokine activation in acute pancreatitis:enhanced release of monocyte chemoattractant protein-1 in patients with local and systemic complications[J]. Intensive Care Med, 2003, 29(4):622-629.
[30] Ethridge RT, Hashimoto K, Chung DH, et al. Selective inhibition of NF-kappaB attenuates the severity of cerulein- induced acute pancreatitis[J]. J Am Coll, 2002, 195(4):497-505.
[31] Virlos I, Mazzon E, Serraino I, et al. Calpain I inhibitor ameliorates the indices of disease severity in a murine model of cerulein-induced acute pancreatitis[J]. Intensive Care Med, 2004, 30(8):1645-1651.